Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722185 · ClinicalTrials.gov registry record · NA
Evaluation of the Veriton SPECT/CT System
A NA study of Focus of Study is Comparison of 2 Types of Gamma Cameras, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT04722185 is a NA study of Focus of Study is Comparison of 2 Types of Gamma Cameras that has completed, run by Mayo Clinic. The registered enrollment target is 41 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04722185, a NA study of Focus of Study is Comparison of 2 Types of Gamma Cameras, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to evaluate a new type of gamma camera (the Veriton system) that provides a significant gain in system sensitivity and improved image quality compared to a conventional gamma camera that can achieve equal or better image quality than a standard SPECT/CT system.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Veriton SPECT/CT
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-01-20 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04722185
The ClinicalTrials.gov registry entry for NCT04722185 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Focus of Study is Comparison of 2 Types of Gamma Cameras appearing as the primary indexed condition, and to 1 intervention - of which Veriton SPECT/CT is the first listed.
NCT04722185 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04722185 about?
NCT04722185 is a clinical study titled "Evaluation of the Veriton SPECT/CT System". The main purpose of this study is to evaluate a new type of gamma camera (the Veriton system) that provides a significant gain in system sensitivity and improved image quality compared to a conventional gamma camera that can achieve equal or better image quality than a standard SPECT/CT system.
What is the current status of trial NCT04722185?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2021-01-20. Estimated completion is 2025-12-31.
What conditions does trial NCT04722185 study?
This clinical trial studies the following conditions: Focus of Study is Comparison of 2 Types of Gamma Cameras.
What interventions are being tested in trial NCT04722185?
The interventions under investigation include: Veriton SPECT/CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04722185?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04722185 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.